FDA.reportPublic FDA data

SELEXIPAG Pharmacologic Class Indexing

Class set ID
cfde73ef-9080-45db-aad3-4576b302e071
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use UPTRAVI safely and effectively. See full prescribing information for UPTRAVI. UPTRAVI ® (selexipag) tablets, for oral use UPTRAVI ® (selexipag) for injection, for intravenous use Initial U.S. Approval: 2015Actelion Pharmaceuticals US, Inc. | Butterworth Laboratories Ltd | Wickham Micro Limited | Almac Sciences Limited | Almac Pharma Services Limited | EUROFINS AMATSIGROUP SAS | Eurofins Amatsi Analytics | SGS Institut Fresenius GmbH | Excella GmbH & Co. KG | Konapharma AG | Confarma France2026052826
These highlights do not include all the information needed to use SELEXIPAG TABLETS safely and effectively. See full prescribing information for SELEXIPAG TABLETS. SELEXIPAG tablets, for oral use Initial U.S. Approval: 2015Zydus Lifesciences Limited202511072
These highlights do not include all the information needed to use SELEXIPAG TABLETS safely and effectively. See full prescribing information for SELEXIPAG TABLETS. SELEXIPAG tablets, for oral use Initial U.S. Approval: 2015Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited202405253